Latest Capital Raise News

Orthocell Limited has reported a record $3.2 million revenue for the December 2025 quarter, marking its seventh consecutive quarter of growth, fuelled by expanding sales of its nerve repair product Remplir in the US and other international markets.

Gateway Mining’s latest aircore drilling at the Yandal Gold Project reveals significant high-grade gold mineralisation near the bottom of holes along key shear structures, expanding the known gold system.

Podium Minerals has made significant strides at its Parks Reef PGM Project, launching a game-changing concentrator flowsheet and progressing a multi-phase drilling campaign, all supported by a successful A$12 million capital raise amid soaring platinum group metal prices.

Buru Energy advances its Rafael Gas Project with strong funding interest and a $2.35 million capital raise, setting the stage for critical 2026 drilling and resource validation.

BPM Minerals has completed its first reverse circulation drilling at the high-grade Beachcomber Prospect, confirming a major gold system across a 75 km corridor and securing $3.5 million to fuel expanded 2026 exploration.

Dreadnought Resources reports a 36% increase in high-grade gold resources at Star of Mangaroon, secures $18 million in funding, and advances critical metals projects with promising drilling results and strategic partnerships.

Alicanto Minerals Limited has announced a 12-for-1 consolidation of its securities, including ordinary shares, performance rights, and options, effective from late January 2026. This move will significantly reduce the number of securities on issue and adjust option exercise prices accordingly.

Finder Energy has completed a $5.2 million capital raise through a share placement to its directors and substantial shareholder Longreach Capital, following shareholder approval.

Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.

Westar Resources reported significant progress in its December 2025 quarterly activities, including new tenement grants and advanced data acquisition at key gold and copper projects. The company also completed a partial capital raise, positioning itself for further exploration.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.